Ghent University Academic Bibliography

Advanced

Bioavailability of hydrochlorothiazide from pellets, made by extrusion/spheronisation, containing polyethylene glycol 400 as a dissolution enhancer.

Chris Vervaet UGent and Jean Paul Remon UGent (1997) PHARMACEUTICAL RESEARCH. 14(11). p.1644-1646
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle
publication status
published
subject
journal title
PHARMACEUTICAL RESEARCH
Pharm. Res.
volume
14
issue
11
pages
1644-1646 pages
Web of Science type
Article
Web of Science id
000070991100024
ISSN
0724-8741
language
English
UGent publication?
yes
classification
A1
id
175922
handle
http://hdl.handle.net/1854/LU-175922
date created
2004-01-14 13:40:00
date last changed
2008-02-22 22:48:22
@article{175922,
  author       = {Vervaet, Chris and Remon, Jean Paul},
  issn         = {0724-8741},
  journal      = {PHARMACEUTICAL RESEARCH},
  language     = {eng},
  number       = {11},
  pages        = {1644--1646},
  title        = {Bioavailability of hydrochlorothiazide from pellets, made by extrusion/spheronisation, containing polyethylene glycol 400 as a dissolution enhancer.},
  volume       = {14},
  year         = {1997},
}

Chicago
Vervaet, Chris, and Jean Paul Remon. 1997. “Bioavailability of Hydrochlorothiazide from Pellets, Made by Extrusion/spheronisation, Containing Polyethylene Glycol 400 as a Dissolution Enhancer.” Pharmaceutical Research 14 (11): 1644–1646.
APA
Vervaet, C., & Remon, J. P. (1997). Bioavailability of hydrochlorothiazide from pellets, made by extrusion/spheronisation, containing polyethylene glycol 400 as a dissolution enhancer. PHARMACEUTICAL RESEARCH, 14(11), 1644–1646.
Vancouver
1.
Vervaet C, Remon JP. Bioavailability of hydrochlorothiazide from pellets, made by extrusion/spheronisation, containing polyethylene glycol 400 as a dissolution enhancer. PHARMACEUTICAL RESEARCH. 1997;14(11):1644–6.
MLA
Vervaet, Chris, and Jean Paul Remon. “Bioavailability of Hydrochlorothiazide from Pellets, Made by Extrusion/spheronisation, Containing Polyethylene Glycol 400 as a Dissolution Enhancer.” PHARMACEUTICAL RESEARCH 14.11 (1997): 1644–1646. Print.